Astrazeneca Pharma India Ltd vs Panjon Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 8233 as of 05 May 15:30 . The P/E Ratio of Astrazeneca Pharma India Ltd changed from 80.7 on March 2021 to 185.9 on March 2025 . This represents a CAGR of 18.16% over 5 yearsThe P/E Ratio of Panjon Ltd changed from 22.4 on March 2023 to 97.8 on March 2025 . This represents a CAGR of 63.44% over 3 years The Market Cap of Astrazeneca Pharma India Ltd changed from ₹ 7525 crore on March 2021 to ₹ 21515 crore on March 2025 . This represents a CAGR of 23.38% over 5 yearsThe Market Cap of Panjon Ltd changed from ₹ 27.28 crore on March 2022 to ₹ 38.6 crore on March 2025 . This represents a CAGR of 9.07% over 4 years The revenue of Astrazeneca Pharma India Ltd for the Dec '25 is ₹ 618.18 crore as compare to the Sep '25 revenue of ₹ 565.26 crore. This represent the growth of 9.36% The revenue of Panjon Ltd for the Dec '25 is ₹ 14.18 crore as compare to the Sep '25 revenue of ₹ 14.99 crore. This represent the decline of -5.4% The ebitda of Astrazeneca Pharma India Ltd for the Dec '25 is ₹ 51.44 crore as compare to the Sep '25 ebitda of ₹ 76.06 crore. This represent the decline of -32.37% The ebitda of Panjon Ltd for the Dec '25 is ₹ 0.33 crore as compare to the Sep '25 ebitda of ₹ 0.31 crore. This represent the growth of 6.45% The net profit of Astrazeneca Pharma India Ltd changed from ₹ -11.79 crore to ₹ 32.59 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Panjon Ltd changed from ₹ 0.03 crore to ₹ 0.22 crore over 7 quarters. This represents a CAGR of 212.22% The Dividend Payout of Astrazeneca Pharma India Ltd changed from 5.36 % on March 2021 to 69.12 % on March 2025 . This represents a CAGR of 66.76% over 5 yearsThe Dividend Payout of Panjon Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Astrazeneca Pharma India Ltd

AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

About Panjon Ltd

Incorporated in Dec.'83 Panjon Limited became public in 1992.
The Company was promoted by Nagin Kothari and Manoj Kothari.
The Company is a leading FMCG company.
It has marked its presence with significant achievements and today commands a remarkable market status.
Panjon today has renowned products like PANJON Tablet , PANJON Balm , PANJON Inhaler, PANJON cough drops, Swad Digestive Drops, Swad Chatpati Drops, Swad Chyawanpra Candy,Percy Masala Candy, Panjon Swad PACHAK range : Shahi Anardana, Special Jeera Goli, Hing Peda, Albela Aam, Khatta Meetha Khajoor, Chatpata Amla, Chulbuli Imli and many more. The Company manufactures and markets consumer and pharmaceutical products which are low priced and within the reach of the common man.

FAQs for the comparison of Astrazeneca Pharma India Ltd and Panjon Ltd

Which company has a larger market capitalization, Astrazeneca Pharma India Ltd or Panjon Ltd?

Market cap of Astrazeneca Pharma India Ltd is 20,116 Cr while Market cap of Panjon Ltd is 40 Cr

What are the key factors driving the stock performance of Astrazeneca Pharma India Ltd and Panjon Ltd?

The stock performance of Astrazeneca Pharma India Ltd and Panjon Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astrazeneca Pharma India Ltd and Panjon Ltd?

As of May 5, 2026, the Astrazeneca Pharma India Ltd stock price is INR ₹8046.55. On the other hand, Panjon Ltd stock price is INR ₹23.61.

How do dividend payouts of Astrazeneca Pharma India Ltd and Panjon Ltd compare?

To compare the dividend payouts of Astrazeneca Pharma India Ltd and Panjon Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.